仟源医药: 董事会薪酬与考核委员会关于2025年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见

Core Viewpoint - The company has approved the 2025 Restricted Stock Incentive Plan and has publicly disclosed the list of initial grant recipients, following the relevant regulations and guidelines [1][2]. Disclosure and Verification - The initial grant recipient list was publicly announced on July 23, 2025, and was open for feedback for a period of 10 days, during which no objections were received [2]. - The Compensation and Assessment Committee verified the eligibility of the initial grant recipients based on their employment contracts, identification documents, and their positions within the company [2]. Committee's Verification Opinion - The Compensation and Assessment Committee confirmed that all selected recipients meet the qualifications set forth in the relevant regulations and do not fall under any disqualifying conditions [3]. - The recipients do not include independent directors, foreign employees, or shareholders holding more than 5% of the company's shares, ensuring compliance with the incentive plan's objectives [3].